 Daniel Frank
Concepts (780)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 730 | 5.960 |
Why?
| | Gastrointestinal Microbiome | 46 | 2025 | 641 | 5.450 |
Why?
| | Rhinitis | 15 | 2022 | 152 | 4.950 |
Why?
| | Sinusitis | 17 | 2023 | 210 | 4.940 |
Why?
| | Bacteria | 34 | 2023 | 821 | 3.300 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 525 | 3.300 |
Why?
| | Metagenome | 15 | 2019 | 141 | 3.190 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 76 | 2.420 |
Why?
| | Intestines | 15 | 2022 | 348 | 2.270 |
Why?
| | Dysbiosis | 18 | 2025 | 169 | 2.210 |
Why?
| | Otitis Media | 8 | 2025 | 160 | 2.180 |
Why?
| | Feces | 24 | 2025 | 440 | 1.980 |
Why?
| | RNA, Bacterial | 12 | 2018 | 183 | 1.610 |
Why?
| | Intestinal Mucosa | 19 | 2020 | 590 | 1.600 |
Why?
| | Nasal Polyps | 5 | 2021 | 59 | 1.490 |
Why?
| | Nose | 4 | 2018 | 63 | 1.450 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 438 | 1.380 |
Why?
| | Nasal Cavity | 6 | 2023 | 51 | 1.330 |
Why?
| | Ileum | 5 | 2020 | 116 | 1.250 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 779 | 1.230 |
Why?
| | Bacteremia | 6 | 2018 | 197 | 1.220 |
Why?
| | Crohn Disease | 6 | 2020 | 217 | 1.170 |
Why?
| | Phylogeny | 25 | 2020 | 852 | 1.170 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 185 | 1.100 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 393 | 1.060 |
Why?
| | Chronic Disease | 17 | 2022 | 1720 | 1.010 |
Why?
| | HIV Infections | 15 | 2025 | 2720 | 0.960 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.910 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 43 | 0.890 |
Why?
| | Clostridium Infections | 4 | 2018 | 64 | 0.860 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 40 | 0.850 |
Why?
| | Humans | 134 | 2025 | 129650 | 0.820 |
Why?
| | Nasopharynx | 5 | 2024 | 67 | 0.820 |
Why?
| | Endoribonucleases | 8 | 2002 | 73 | 0.810 |
Why?
| | Biodiversity | 13 | 2020 | 380 | 0.810 |
Why?
| | Bacterial Infections | 3 | 2015 | 237 | 0.790 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.790 |
Why?
| | Cholesteatoma | 1 | 2022 | 11 | 0.780 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 320 | 0.770 |
Why?
| | Inflammation Mediators | 3 | 2023 | 505 | 0.750 |
Why?
| | Breast Feeding | 6 | 2023 | 424 | 0.740 |
Why?
| | RNA, Catalytic | 7 | 2001 | 185 | 0.740 |
Why?
| | Database Management Systems | 2 | 2013 | 48 | 0.720 |
Why?
| | Drinking Water | 1 | 2022 | 76 | 0.710 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.700 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.690 |
Why?
| | User-Computer Interface | 2 | 2013 | 149 | 0.680 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 100 | 0.680 |
Why?
| | Inflammation | 12 | 2023 | 2736 | 0.680 |
Why?
| | Male | 67 | 2025 | 63681 | 0.670 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2832 | 0.670 |
Why?
| | Software | 3 | 2021 | 608 | 0.660 |
Why?
| | Colon | 8 | 2023 | 254 | 0.650 |
Why?
| | Female | 76 | 2025 | 68776 | 0.650 |
Why?
| | Burns | 4 | 2025 | 286 | 0.650 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1038 | 0.640 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 138 | 0.640 |
Why?
| | Infant Food | 2 | 2025 | 65 | 0.620 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.620 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 137 | 0.620 |
Why?
| | HIV-1 | 8 | 2024 | 836 | 0.600 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 119 | 0.600 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 429 | 0.590 |
Why?
| | Animals | 54 | 2025 | 35361 | 0.590 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 162 | 0.580 |
Why?
| | Iron | 3 | 2017 | 288 | 0.580 |
Why?
| | Adult | 44 | 2025 | 35576 | 0.570 |
Why?
| | Genes, rRNA | 3 | 2015 | 41 | 0.570 |
Why?
| | Fatty Liver | 2 | 2021 | 231 | 0.560 |
Why?
| | Vagina | 5 | 2016 | 175 | 0.540 |
Why?
| | Middle Aged | 37 | 2025 | 31154 | 0.530 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 544 | 0.530 |
Why?
| | Membrane Proteins | 3 | 2021 | 1119 | 0.530 |
Why?
| | Pharynx | 1 | 2016 | 58 | 0.510 |
Why?
| | Nose Diseases | 1 | 2016 | 12 | 0.510 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 15 | 0.510 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 261 | 0.510 |
Why?
| | Diet | 8 | 2025 | 1213 | 0.510 |
Why?
| | Case-Control Studies | 15 | 2020 | 3381 | 0.500 |
Why?
| | Mice | 28 | 2025 | 16937 | 0.490 |
Why?
| | Biofilms | 5 | 2016 | 244 | 0.490 |
Why?
| | Base Sequence | 18 | 2015 | 2142 | 0.490 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 137 | 0.490 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 63 | 0.470 |
Why?
| | Immunity, Innate | 4 | 2019 | 804 | 0.470 |
Why?
| | Endotoxemia | 2 | 2014 | 86 | 0.470 |
Why?
| | Food | 2 | 2020 | 157 | 0.470 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5066 | 0.450 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 130 | 0.450 |
Why?
| | Genome, Bacterial | 4 | 2016 | 134 | 0.430 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 46 | 0.430 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 178 | 0.430 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.420 |
Why?
| | Hippocampus | 1 | 2018 | 874 | 0.420 |
Why?
| | Lactobacillus | 4 | 2022 | 26 | 0.420 |
Why?
| | Lipid Metabolism | 2 | 2020 | 497 | 0.410 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 94 | 0.410 |
Why?
| | Iron, Dietary | 1 | 2013 | 21 | 0.410 |
Why?
| | Immunoglobulin A | 4 | 2022 | 200 | 0.410 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 352 | 0.410 |
Why?
| | Liver | 4 | 2020 | 1839 | 0.400 |
Why?
| | Ear, Middle | 6 | 2025 | 91 | 0.400 |
Why?
| | Bacterial Load | 1 | 2012 | 66 | 0.400 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 221 | 0.390 |
Why?
| | Smoking | 2 | 2020 | 1501 | 0.390 |
Why?
| | Genitalia, Female | 1 | 2012 | 38 | 0.390 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 198 | 0.380 |
Why?
| | Probiotics | 5 | 2018 | 51 | 0.380 |
Why?
| | Diet, High-Fat | 3 | 2019 | 239 | 0.380 |
Why?
| | Mice, Inbred C57BL | 15 | 2025 | 5440 | 0.380 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1717 | 0.370 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 367 | 0.360 |
Why?
| | Genomics | 4 | 2020 | 716 | 0.350 |
Why?
| | Livestock | 1 | 2010 | 6 | 0.350 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 170 | 0.350 |
Why?
| | Obesity | 7 | 2023 | 2883 | 0.350 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 22 | 0.350 |
Why?
| | Stress, Psychological | 1 | 2018 | 1066 | 0.340 |
Why?
| | Computational Biology | 3 | 2019 | 599 | 0.340 |
Why?
| | Asthma | 2 | 2015 | 2230 | 0.340 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 9 | 0.340 |
Why?
| | Escherichia coli | 9 | 2017 | 774 | 0.340 |
Why?
| | Fucosyltransferases | 2 | 2022 | 32 | 0.340 |
Why?
| | DNA Primers | 3 | 2009 | 510 | 0.340 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 57 | 0.340 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 19 | 0.340 |
Why?
| | Bacterial Translocation | 4 | 2019 | 40 | 0.330 |
Why?
| | Agriculture | 1 | 2010 | 93 | 0.330 |
Why?
| | Weight Loss | 3 | 2021 | 734 | 0.330 |
Why?
| | Genome | 2 | 2009 | 278 | 0.330 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 128 | 0.330 |
Why?
| | Fluoroquinolones | 1 | 2009 | 45 | 0.330 |
Why?
| | Catheterization | 2 | 2009 | 175 | 0.320 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 35 | 0.310 |
Why?
| | Behavior Therapy | 2 | 2021 | 241 | 0.310 |
Why?
| | Butyrates | 2 | 2021 | 56 | 0.310 |
Why?
| | Wound Infection | 1 | 2009 | 29 | 0.310 |
Why?
| | Corynebacterium | 4 | 2022 | 48 | 0.310 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1092 | 0.310 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 2 | 0.300 |
Why?
| | Infant | 16 | 2025 | 9024 | 0.300 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 875 | 0.300 |
Why?
| | Confidentiality | 1 | 2008 | 68 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| | Seafood | 2 | 2025 | 27 | 0.290 |
Why?
| | Milk, Human | 4 | 2023 | 151 | 0.290 |
Why?
| | Transcriptome | 5 | 2021 | 887 | 0.290 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 14 | 0.290 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 163 | 0.290 |
Why?
| | Pedigree | 4 | 2025 | 487 | 0.290 |
Why?
| | DNA, Bacterial | 6 | 2017 | 324 | 0.290 |
Why?
| | Video Recording | 1 | 2008 | 164 | 0.280 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 33 | 0.280 |
Why?
| | Pneumonia | 2 | 2025 | 616 | 0.280 |
Why?
| | Genes, Bacterial | 5 | 2018 | 157 | 0.270 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 308 | 0.270 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 83 | 0.270 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4063 | 0.270 |
Why?
| | RNA, Transfer | 3 | 1998 | 130 | 0.270 |
Why?
| | Congresses as Topic | 1 | 2008 | 216 | 0.270 |
Why?
| | Aged | 16 | 2023 | 22103 | 0.270 |
Why?
| | Homeostasis | 5 | 2020 | 611 | 0.270 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.260 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 706 | 0.260 |
Why?
| | Carrier Proteins | 1 | 2010 | 743 | 0.260 |
Why?
| | Genotype | 4 | 2019 | 1839 | 0.260 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 59 | 0.260 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3628 | 0.260 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 83 | 0.250 |
Why?
| | Dietary Supplements | 3 | 2019 | 534 | 0.250 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1106 | 0.250 |
Why?
| | Public Health | 1 | 2010 | 484 | 0.250 |
Why?
| | Neoplasms | 2 | 2018 | 2470 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2282 | 0.250 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 87 | 0.240 |
Why?
| | Diet, Western | 3 | 2022 | 79 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Research | 1 | 2008 | 416 | 0.240 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 588 | 0.240 |
Why?
| | Phenotype | 8 | 2020 | 3076 | 0.240 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 159 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 13 | 0.230 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 487 | 0.230 |
Why?
| | Cohort Studies | 7 | 2022 | 5420 | 0.230 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 386 | 0.230 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 195 | 0.230 |
Why?
| | Palatine Tonsil | 1 | 2024 | 45 | 0.230 |
Why?
| | Air Microbiology | 2 | 2015 | 40 | 0.220 |
Why?
| | Young Adult | 13 | 2024 | 12426 | 0.220 |
Why?
| | Glycerophospholipids | 1 | 2024 | 34 | 0.220 |
Why?
| | Biomarkers | 9 | 2024 | 3973 | 0.220 |
Why?
| | Infant Formula | 2 | 2023 | 74 | 0.220 |
Why?
| | Pregnancy | 11 | 2025 | 6402 | 0.220 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 153 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 110 | 0.210 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 29 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 94 | 0.210 |
Why?
| | RNA, Fungal | 5 | 2002 | 67 | 0.210 |
Why?
| | Colitis | 3 | 2020 | 242 | 0.210 |
Why?
| | RNA Splicing | 3 | 1995 | 262 | 0.210 |
Why?
| | Adolescent | 13 | 2024 | 20393 | 0.210 |
Why?
| | Ear Canal | 1 | 2003 | 15 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2025 | 218 | 0.200 |
Why?
| | Sepsis | 2 | 2023 | 574 | 0.200 |
Why?
| | Species Specificity | 4 | 2020 | 575 | 0.200 |
Why?
| | Ribonuclease P | 7 | 2001 | 25 | 0.200 |
Why?
| | Gene Ontology | 1 | 2022 | 51 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.200 |
Why?
| | Fungal Proteins | 2 | 2000 | 130 | 0.200 |
Why?
| | Genetic Variation | 4 | 2018 | 937 | 0.200 |
Why?
| | Olfaction Disorders | 1 | 2023 | 60 | 0.200 |
Why?
| | Disease Susceptibility | 3 | 2020 | 333 | 0.200 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.190 |
Why?
| | Exome | 2 | 2020 | 220 | 0.190 |
Why?
| | Mycobacterium | 1 | 2023 | 106 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 375 | 0.190 |
Why?
| | Child, Preschool | 10 | 2025 | 10517 | 0.190 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 107 | 0.190 |
Why?
| | Immunity | 2 | 2014 | 139 | 0.190 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 480 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1056 | 0.190 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 51 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 39 | 0.190 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 207 | 0.180 |
Why?
| | Child | 12 | 2025 | 20883 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 182 | 0.180 |
Why?
| | Genes, Fungal | 4 | 2000 | 50 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.180 |
Why?
| | Nutritional Status | 2 | 2014 | 328 | 0.180 |
Why?
| | Health | 2 | 2012 | 74 | 0.180 |
Why?
| | Ascomycota | 1 | 2000 | 31 | 0.170 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 31 | 0.170 |
Why?
| | Islets of Langerhans | 3 | 2015 | 791 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 532 | 0.170 |
Why?
| | Aged, 80 and over | 6 | 2021 | 7086 | 0.170 |
Why?
| | Firmicutes | 2 | 2021 | 18 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Mice, Nude | 1 | 2022 | 683 | 0.170 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 275 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 69 | 0.170 |
Why?
| | Carcinogenesis | 1 | 2022 | 213 | 0.170 |
Why?
| | Mouth | 1 | 2020 | 84 | 0.170 |
Why?
| | Body Mass Index | 5 | 2020 | 2273 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 12 | 0.170 |
Why?
| | Mice, Knockout | 5 | 2022 | 2871 | 0.170 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 111 | 0.160 |
Why?
| | Autoimmunity | 3 | 2015 | 862 | 0.160 |
Why?
| | Vascular Remodeling | 1 | 2021 | 192 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2025 | 5762 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 19 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 9 | 0.160 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 53 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 231 | 0.160 |
Why?
| | Vitamin B Complex | 1 | 2019 | 41 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 169 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Restraint, Physical | 1 | 2018 | 68 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2073 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 352 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 317 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 129 | 0.150 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2004 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 122 | 0.150 |
Why?
| | Microbiological Techniques | 2 | 2016 | 30 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Rats | 8 | 2023 | 5500 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 96 | 0.150 |
Why?
| | Random Allocation | 1 | 2018 | 346 | 0.140 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 118 | 0.140 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 21 | 0.140 |
Why?
| | Evolution, Molecular | 2 | 2018 | 466 | 0.140 |
Why?
| | Ethanol | 1 | 2022 | 589 | 0.140 |
Why?
| | Immunoglobulin D | 1 | 2017 | 29 | 0.140 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 45 | 0.140 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 7 | 0.140 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 170 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7133 | 0.140 |
Why?
| | Lung | 4 | 2022 | 3930 | 0.140 |
Why?
| | Alcohol Drinking | 1 | 2024 | 764 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2018 | 118 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2018 | 106 | 0.140 |
Why?
| | Birth Weight | 1 | 2020 | 505 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 96 | 0.140 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 41 | 0.140 |
Why?
| | Water Microbiology | 3 | 2016 | 85 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.140 |
Why?
| | Ceftriaxone | 1 | 2016 | 19 | 0.130 |
Why?
| | Metals | 1 | 1997 | 128 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 481 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 339 | 0.130 |
Why?
| | Micronutrients | 1 | 2017 | 88 | 0.130 |
Why?
| | Autoantibodies | 3 | 2022 | 1466 | 0.130 |
Why?
| | beta-Lactamases | 1 | 2016 | 41 | 0.130 |
Why?
| | Metabolome | 1 | 2020 | 338 | 0.130 |
Why?
| | Gene Expression | 2 | 2018 | 1472 | 0.130 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 17 | 0.130 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 50 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 54 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 120 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2018 | 2708 | 0.130 |
Why?
| | Bacillus | 1 | 2015 | 15 | 0.130 |
Why?
| | Cholesterol | 3 | 2023 | 412 | 0.130 |
Why?
| | Gelatin | 1 | 2016 | 42 | 0.130 |
Why?
| | Binding Sites | 6 | 1998 | 1252 | 0.130 |
Why?
| | Symbiosis | 2 | 2017 | 71 | 0.130 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 125 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2017 | 720 | 0.130 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 9 | 0.130 |
Why?
| | Antibiosis | 1 | 2015 | 9 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 640 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 75 | 0.120 |
Why?
| | Streptococcus mitis | 1 | 2015 | 9 | 0.120 |
Why?
| | Hospitalization | 3 | 2018 | 2070 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Metagenomics | 2 | 2019 | 156 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 301 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 38 | 0.120 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 21 | 0.120 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.120 |
Why?
| | Hysterectomy | 1 | 2016 | 118 | 0.120 |
Why?
| | Thrombophilia | 1 | 2016 | 81 | 0.120 |
Why?
| | Catalase | 1 | 2015 | 129 | 0.120 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 57 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 241 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 33 | 0.120 |
Why?
| | Thrombin | 1 | 2016 | 146 | 0.120 |
Why?
| | Double-Blind Method | 3 | 2017 | 1876 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 63 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 80 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 175 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 170 | 0.120 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 80 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1952 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Carrier State | 1 | 2015 | 60 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 146 | 0.120 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 85 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 219 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.120 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 91 | 0.120 |
Why?
| | Humidity | 1 | 2014 | 49 | 0.120 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 112 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 215 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 566 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 101 | 0.110 |
Why?
| | Physical Exertion | 1 | 2015 | 205 | 0.110 |
Why?
| | Gentamicins | 1 | 2015 | 54 | 0.110 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 1001 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2015 | 122 | 0.110 |
Why?
| | Bifidobacterium | 3 | 2022 | 21 | 0.110 |
Why?
| | Adiposity | 2 | 2018 | 504 | 0.110 |
Why?
| | Biota | 1 | 2014 | 35 | 0.110 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1084 | 0.110 |
Why?
| | Maternal Welfare | 1 | 2014 | 19 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 573 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 985 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 140 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 42 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 27 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 940 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 958 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 59 | 0.110 |
Why?
| | Preconception Care | 1 | 2014 | 41 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2014 | 85 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 752 | 0.110 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 165 | 0.110 |
Why?
| | Cytokines | 4 | 2023 | 2017 | 0.110 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.110 |
Why?
| | Bacteroidetes | 3 | 2021 | 23 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 207 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 572 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 107 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 616 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 559 | 0.100 |
Why?
| | Zinc Fingers | 1 | 1992 | 44 | 0.100 |
Why?
| | Burkina Faso | 1 | 2012 | 4 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 601 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 29 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 260 | 0.100 |
Why?
| | Aerosols | 1 | 2013 | 170 | 0.100 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 64 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2018 | 835 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 718 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 131 | 0.090 |
Why?
| | Skin | 1 | 2016 | 725 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 276 | 0.090 |
Why?
| | Genetics, Medical | 1 | 2011 | 24 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 522 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 158 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 532 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 769 | 0.090 |
Why?
| | Viruses | 1 | 2012 | 100 | 0.090 |
Why?
| | Lactation | 1 | 2012 | 170 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 372 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1385 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 240 | 0.090 |
Why?
| | Nutritive Value | 1 | 2010 | 36 | 0.090 |
Why?
| | Food Safety | 1 | 2010 | 18 | 0.090 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 42 | 0.090 |
Why?
| | Insulin | 2 | 2022 | 2326 | 0.080 |
Why?
| | Amphotericin B | 1 | 2010 | 29 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2010 | 28 | 0.080 |
Why?
| | Risk Factors | 4 | 2018 | 9765 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2018 | 10230 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1367 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1894 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 30 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 25 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 78 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 482 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 75 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2022 | 14518 | 0.080 |
Why?
| | Prevalence | 2 | 2014 | 2564 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 80 | 0.080 |
Why?
| | Montana | 1 | 2009 | 18 | 0.080 |
Why?
| | Fatty Acids | 3 | 2022 | 427 | 0.080 |
Why?
| | Mississippi | 1 | 2009 | 21 | 0.080 |
Why?
| | Prostatectomy | 1 | 2009 | 106 | 0.080 |
Why?
| | Biomass | 1 | 2009 | 126 | 0.080 |
Why?
| | Sequence Alignment | 3 | 2001 | 332 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 623 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 857 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2017 | 1156 | 0.080 |
Why?
| | Permeability | 2 | 2022 | 157 | 0.080 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 138 | 0.080 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 110 | 0.080 |
Why?
| | Systems Integration | 1 | 2008 | 38 | 0.080 |
Why?
| | Environment | 1 | 2010 | 343 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 310 | 0.080 |
Why?
| | Housing | 1 | 2009 | 130 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2441 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 636 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 70 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2717 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 568 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 147 | 0.070 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 152 | 0.070 |
Why?
| | Prognosis | 2 | 2020 | 3794 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 108 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2548 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 41 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 737 | 0.070 |
Why?
| | Child Development | 1 | 2012 | 457 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 218 | 0.070 |
Why?
| | Plasmids | 4 | 2016 | 358 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2010 | 328 | 0.070 |
Why?
| | Research Personnel | 1 | 2008 | 156 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 221 | 0.070 |
Why?
| | Indomethacin | 1 | 2006 | 78 | 0.070 |
Why?
| | Peptic Ulcer | 1 | 2006 | 18 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 548 | 0.070 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 27 | 0.070 |
Why?
| | Proteobacteria | 2 | 2017 | 16 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 27 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 46 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 106 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 417 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 467 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 847 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 840 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 189 | 0.060 |
Why?
| | Artificial Intelligence | 1 | 2008 | 246 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 150 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 14 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 53 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1053 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 26 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 60 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 524 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 649 | 0.060 |
Why?
| | Age Factors | 2 | 2025 | 3144 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3083 | 0.060 |
Why?
| | Oropharynx | 1 | 2024 | 44 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2005 | 295 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 315 | 0.060 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 88 | 0.060 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 67 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 61 | 0.060 |
Why?
| | Comorbidity | 1 | 2009 | 1547 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 178 | 0.060 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 149 | 0.050 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 11 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 78 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 32 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 48 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 29 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1736 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1198 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 339 | 0.050 |
Why?
| | Cats | 1 | 2004 | 208 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2406 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 108 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 544 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 38 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1587 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 586 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 10 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 52 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 819 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 33 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 448 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 56 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 42 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 226 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 179 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 91 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 308 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 255 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2002 | 86 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1622 | 0.050 |
Why?
| | Smell | 1 | 2023 | 137 | 0.050 |
Why?
| | Japan | 1 | 2021 | 98 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 361 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 47 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 199 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 434 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 622 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 375 | 0.050 |
Why?
| | Pigments, Biological | 1 | 2001 | 16 | 0.050 |
Why?
| | Diet, Reducing | 1 | 2021 | 87 | 0.050 |
Why?
| | RNA, Archaeal | 1 | 2001 | 16 | 0.050 |
Why?
| | Systole | 1 | 2021 | 191 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 138 | 0.040 |
Why?
| | Tight Junctions | 1 | 2021 | 75 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4897 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1480 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 72 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 145 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 83 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 246 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 74 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 345 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 376 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 436 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 100 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 91 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1698 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 111 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 66 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 520 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 267 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 218 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 155 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 75 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 118 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 356 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6556 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3717 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 625 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 119 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 150 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 179 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 310 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 209 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 368 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 129 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 118 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 2 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 185 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 47 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 3 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.040 |
Why?
| | Acute Disease | 2 | 2016 | 980 | 0.040 |
Why?
| | Syndecan-1 | 1 | 2017 | 27 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 153 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 582 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 521 | 0.040 |
Why?
| | Powders | 1 | 2017 | 43 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 81 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 457 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 67 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 161 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 441 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1003 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 77 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 7 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1245 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 786 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 63 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 88 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 204 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 30 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 38 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 116 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 58 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 458 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 781 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 262 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 26 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2742 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 7 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 275 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 23 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 749 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 697 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 107 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 252 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 811 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 162 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 56 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 24 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 592 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 340 | 0.030 |
Why?
| | North America | 1 | 2016 | 291 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 47 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 85 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 352 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 58 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 29 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 507 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 20 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 391 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1007 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 159 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 2 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 88 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 652 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 5 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 25 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 472 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 46 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 75 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.030 |
Why?
| | Methane | 1 | 2014 | 48 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 265 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 152 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2012 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 31 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 62 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 315 | 0.030 |
Why?
| | Geography | 1 | 2014 | 188 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 594 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 376 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 24 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1994 | 179 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 266 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 333 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 248 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 406 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 502 | 0.030 |
Why?
| | New York City | 1 | 2013 | 81 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 338 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 180 | 0.030 |
Why?
| | Endoscopy | 1 | 2015 | 285 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 1992 | 14 | 0.030 |
Why?
| | Genes, Lethal | 1 | 1992 | 29 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2781 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1776 | 0.030 |
Why?
| | Staphylococcus | 1 | 2013 | 74 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 81 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 280 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 368 | 0.020 |
Why?
| | Cattle | 2 | 2005 | 976 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 474 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 489 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 179 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 283 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 729 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 331 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1502 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 42 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 388 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2635 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 573 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 422 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 87 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 372 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 385 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1269 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 586 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 478 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4925 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 770 | 0.020 |
Why?
| | Milk | 1 | 2012 | 120 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 124 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 330 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 412 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 104 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3240 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 431 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 637 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2097 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 232 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 874 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1205 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 601 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2704 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1097 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 387 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1288 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 451 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 7 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 835 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 284 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 37 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 14 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 197 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3408 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2058 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1706 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1443 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 400 | 0.020 |
Why?
| | RNA | 1 | 2013 | 883 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1348 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 925 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 28 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1052 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 638 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 485 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2391 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2005 | 157 | 0.020 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 13 | 0.020 |
Why?
| | Culture Media | 1 | 2005 | 162 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 2483 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 135 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 296 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 859 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2503 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 118 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 111 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 302 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 77 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 45 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1040 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1206 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1838 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 493 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 56 | 0.010 |
Why?
| | United States | 1 | 2015 | 13903 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 186 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 65 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 25 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 52 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 181 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1642 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4083 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 480 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 26 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 44 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 81 | 0.010 |
Why?
| | Genes | 1 | 1989 | 226 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 312 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1304 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|